Browsing Category
DCAT Member Company Community
128 posts
ICYMI: DCAT Production to Prescription Podcast: “Headwinds or Tailwinds: Will the Biotech Sector Rebound in 2025?”
By
Biotech companies are an important source for innovation and product development for larger companies and are an important customer base of CDMOs/CMOs. Capital flow in the biotech sector, a key…
DCAT Awards Grants To Student Scientists at the 2025 Regeneron International Science & Engineering Fair
By
The Drug, Chemical & Associated Technologies Association (DCAT) has awarded $30,000 in grants to student scientists of four projects who participated in the Regeneron International Science & Engineering Fair (Regeneron…
New Podcast Episode! Biomanufacturing: How are Industry Capacity & Supply Chains Trending?
By
What is industry capacity utilization for biomanufacturing among the major systems/platforms (mammalian, microbial, and advanced therapies)? Is there too much capacity or is the market tight? The latest episode of…
New! Production to Prescription Podcast: Parenteral Drug Manufacturing—CDMO Outlook: A Capacity Crunch or Easing?
By
What will be the key issues in the CDMO space for parenteral drug manufacturing in 2025? The latest episode of DCAT Value Chain Insights’ original podcast Production to Prescription, examines…
Applications Extended to January 24 for DCAT Week Program, Partnering for Innovation in Manufacturing & Supply
By
How are bio/pharma companies and their partners collaborating to resolve the difficult challenges that arise in development, manufacturing, and the supply chain? DCAT Member Companies are invited to apply to…